Serenella Venanzi

Long-term survival and cure fraction estimates for childhood cancer in Europe (EUROCARE-6): results from a population-based study

Laura Botta, Gemma Gatta, Riccardo Capocaccia et al. · The Lancet Oncology · 2022 · 167 citations · Full text

Cure Fraction Estimates, Cancer Epidemiology, Childhood Cancer +9

SOS1 mutations in Noonan syndrome: molecular spectrum, structural insights on pathogenic effects, and genotype-phenotype correlations

Francesca Romana Lepri, Alessandro De Luca, Lorenzo Stella et al. · Human Mutation · 2011 · 126 citations · Full text

Complete cancer prevalence in Europe in 2020 by disease duration and country (EUROCARE-6): a population-based study

Roberta De Angelis, Elena Demuru, Paolo Baili et al. · The Lancet Oncology · 2024 · 95 citations · Full text

Disease Duration, Epidemiology, Population-based Study +13

Differential expression of the HMG box transcription factors XTcf-3 and XLef-1 during early Xenopus development

Miranda Molenaar, Jeroen P. Roose, Josi Peterson et al. · Mechanisms of Development · 1998 · 76 citations

Transcriptional Regulation, Developmental Biology, Differential Expression +9

Counteracting Effects Operating on Src Homology 2 Domain-containing Protein-tyrosine Phosphatase 2 (SHP2) Function Drive Selection of the Recurrent Y62D and Y63C Substitutions in Noonan Syndrome*

Simone Martinelli, Aurelio Pio Nardozza, Silvia Delle Vigne et al. · Journal of Biological Chemistry · 2012 · 41 citations · Full text